TY - CHAP M1 - Book, Section TI - Treatment of Ischemic Heart Disease A1 - Eschenhagen, Thomas A2 - Brunton, Laurence L. A2 - Knollmann, Björn C. Y1 - 2023 N1 - T2 - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition AB - AbbreviationsACE: angiotensin-converting enzymeACEI: angiotensin-converting enzyme inhibitorACS: acute coronary syndromeALDH2: mitochondrial aldehyde dehydrogenaseARB: angiotensin receptor blockerAV: atrioventricularCAD: coronary artery diseaseCOX-1: cyclooxygenase isoform 1CYP: cytochrome P450ECG: electrocardiogramEMA: European Medicines AgencyeNOS: endothelial NOSFFA: free fatty acidGI: gastrointestinalGp: glycoproteinGTN: glyceryl trinitrate (nitroglycerin)HCM: hypertrophic cardiomyopathyHCN: hyperpolarization-activated cyclic nucleotide–gatedHMG-CoA: 3-hydroxy-3-methylglutaryl coenzyme AiNOS: inducible NOSIP3: inositol 1,4,5-trisphosphateISDN: isosorbide dinitrateISMN: isosorbide-5-mononitrateLDL: low-density lipoproteinMI: myocardial infarctionNET: neutrophil extracellular trapnNOS: neuronal NOSNO: nitric oxideNOS: nitric oxide synthasePAD: peripheral arterial diseasePDE: cyclic nucleotide phosphodiesterasePgp: P-glycoproteinPLC: phospholipase CrTPA: recombinant tissue plasminogen activatorSA: sinoatrialSTEMI: ST-segment elevation myocardial infarctionTxA2: thromboxane A2 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - hemonc.mhmedical.com/content.aspx?aid=1193232586 ER -